搜索筛选:
搜索耗时4.5550秒,为你在为你在102,285,761篇论文里面共找到 13 篇相符的论文内容
发布年度:
[期刊论文] 作者：Hui-Yan Luo,Rui-Hua Xu,,
来源：World Journal of Gastroenterology 年份：2014
Colorectal cancer(CRC)is one of the most common human malignant diseases and the second leading cause of cancer-related deaths worldwide.The treatment of advanc...
[期刊论文] 作者：Hai-Bo Qiu,Li-Yi Zhang,Zhao-Lei Zeng,Zhi-Qiang Wang,Hui-Yan Luo,Rajiv Prasad Keshari,Zhi-Wei Zhou,Rui-Hua,
来源：世界胃肠病学杂志（英文版） 年份：2011
...
Adjuvant chemotherapy,p53,carcinoembryonic antigen expression and prognosis after D2 gastrectomy for
[期刊论文] 作者：Ming-Ming He,Dong-Sheng Zhang,Feng Wang,Zhi-Qiang Wang,Hui-Yan Luo,Chao Ren,Ying Jin,Dong-Liang Chen,,
来源：World Journal of Gastroenterology 年份：2004
AIM:To investigate adjuvant chemotherapy,p53 and carcinoembryonic antigen(CEA)expression and prognosis after D2 gastrectomy for stageⅡ/Ⅲgastric adenocarcinoma...
Phase Ⅱ study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metast
[期刊论文] 作者：Zhi-Qiang Wang,Dong-Sheng Zhang,Nong Xu,De-Yun Luo,Yan-Hong Deng,Feng-Hua Wang,Hui-Yan Luo,Miao-Zhen,
来源：Chinese Journal of Cancer 年份：2016
Background:Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer.This phase II study was conducted to evaluate the efficacy and s...
Phase Ⅱ study of oxaliplatin combined with S-1 and leucovorin(SOL)for Chinese patients with metastat
[会议论文] 作者：Zhi-Qiang Wang,Yu-Hong Li,Feng-Hua Wang,Dong-Sheng Zhang,Rui-Hua Xu,Hui-Yan Luo,Miao-Zhen Qiu,Nong Xu,
来源：第四届广州国际肿瘤学会议 年份：2015
Introduction: Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer....
Phase Ⅱ study of oxaliplatin combined with S-1 and leucovorin(SOL)for Chinese patients with metastat
[会议论文] 作者：Zhi-Qiang Wang,Dong-Sheng Zhang,Nong Xu,De-Yun Luo,Yan-Hong Deng,Feng-Hua Wang,Hui-Yan Luo,Miao-Zhen,
来源：第四届广州国际肿瘤学会议 年份：2015
Introduction: Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer....
[期刊论文] 作者：Wen-Jing Wu,Dong-Liang Chen,Zhao-Lei Zeng,Rui-Yu Wang,Ya-Xin Huang,Ying Jin,Feng Wang,Miao-Zhen Qiu,Hui-Yan Luo,
来源：World Journal of Gastroenterology 年份：2014
AIM:To explore the association between AT-rich interactive domain 1A(ARID1A)protein loss by immunohistochemistry and both clinicopathologic characteristics and...
Temporal Change in Treatment Patterns of Metastatic Colorectal Cancer and Its Association with Patie
[期刊论文] 作者：Zi-Xian Wang,Yi-Chen Yao,Zong-Jiong Mai,Wu-Hao Lin,You-Sheng Huang,Ying Jin,Hui-Yan Luo,Dong-Sheng Zhang,
来源：工程(英文) 年份：2021
There is a lack of high-quality,large-scale,real-world evidence from patients with metastatic colorectal cancer(mCRC),especially in China.It remains unclear whether efforts to improve the quality of care for mCRC would improve patient survi......
[期刊论文] 作者：De-Shen Wang,Ming-Tao Hu,Zhi-Qiang Wang,Chao Ren,Miao-Zhen Qiu,Hui-Yan Luo,Ying Jin,William Pat Fong,,
来源：癌症 年份：2022
背景与目的 预防化疗所致恶心呕吐在肿瘤治疗的全程管理中是十分重要的一环.本研究评价了在高危女性胃肠道肿瘤患者中,在帕洛诺司琼、地塞米松基础上联用阿瑞匹坦能否进一步预防或减轻FOLFIRI方案(氟尿嘧啶、亚叶酸和伊立替康)或FOLFOX方案(氟尿嘧啶、亚叶酸和......
[期刊论文] 作者：Feng Wang,Long Bai,Tian-Shu Liu,Yi-Yi Yu,Ming-Ming He,Kai-Yan Liu,Hui-Yan Luo,Dong-Sheng Zhang,Yin Jin,
来源：Chinese Journal of Cancer 年份：2015
Introduction: Right-sided colon cancer(RSCC) and left-sided colorectal cancer(LSCRC) differ with respect to their biology and genomic patterns. This study aimed...
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Wang,Long Bai,Dong-liang Chen,Miao-zhen Qiu,Chao Ren,Huai-qiang Ju,Yu-hong Li,Dong-sheng Zhang,Hui-yan Luo,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of...
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Zhe-zhen Li,Chao Ren,Dong-sheng Zhang,Qi Zhao,De-shen Wang,Dong-liang Chen,Yun-xin Lu,Huai-qiang Ju,Hui-yan Luo,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of metastatic colorectal cancer(mCRC)in Chinese...
Mutation profiling in Chinese patients with metastatic colorectal cancer and its correlation with cl
[会议论文] 作者：Wang,Zhe-Zhen Li,Zi-Chen Zhang,Fang Wang,Qi Zhao,Dong-sheng Zhang,Feng-hua Wang,Zhi-qiang Wang,Hui-yan Luo,
来源：第四届广州国际肿瘤学会议 年份：2015
An increasing number of studies reveal the significance of genetic markers in guiding target treatment and refining prognosis.This study aims to assess the mutation profile of metastatic colorectal ca...
相关搜索：
